By detecting the levels of MLH1 in CRC cell lines and CRC tissues infected by F. nucleatum, we confirmed that it induces downregulation of the MLH1 protein and causes dMMR, heralding the potential to augment the effect of immunotherapy in patients with MSS. This evidence concerns the gene MLH1 and colorectal carcinoma.